key: cord-0839571-i5d3phyz
authors: Alizadehsani, Roohallah; Alizadeh Sani, Zahra; Behjati, Mohaddeseh; Roshanzamir, Zahra; Hussain, Sadiq; Abedini, Niloofar; Hasanzadeh, Fereshteh; Khosravi, Abbas; Shoeibi, Afshin; Roshanzamir, Mohamad; Moradnejad, Pardis; Nahavandi, Saeid; Khozeimeh, Fahime; Zare, Assef; Panahiazar, Maryam; Acharya, U. Rajendra; Islam, Sheikh Mohammed Shariful
title: Risk factors prediction, clinical outcomes, and mortality in COVID‐19 patients
date: 2020-12-17
journal: J Med Virol
DOI: 10.1002/jmv.26699
sha: fa637aab6f7235a1057b7211c757c076f0624399
doc_id: 839571
cord_uid: i5d3phyz

Preventing communicable diseases requires understanding the spread, epidemiology, clinical features, progression, and prognosis of the disease. Early identification of risk factors and clinical outcomes might help in identifying critically ill patients, providing appropriate treatment, and preventing mortality. We conducted a prospective study in patients with flu‐like symptoms referred to the imaging department of a tertiary hospital in Iran between March 3, 2020, and April 8, 2020. Patients with COVID‐19 were followed up after two months to check their health condition. The categorical data between groups were analyzed by Fisher's exact test and continuous data by Wilcoxon rank‐sum test. Three hundred and nineteen patients (mean age 45.48 ± 18.50 years, 177 women) were enrolled. Fever, dyspnea, weakness, shivering, C‐reactive protein, fatigue, dry cough, anorexia, anosmia, ageusia, dizziness, sweating, and age were the most important symptoms of COVID‐19 infection. Traveling in the past 3 months, asthma, taking corticosteroids, liver disease, rheumatological disease, cough with sputum, eczema, conjunctivitis, tobacco use, and chest pain did not show any relationship with COVID‐19. To the best of our knowledge, a number of factors associated with mortality due to COVID‐19 have been investigated for the first time in this study. Our results might be helpful in early prediction and risk reduction of mortality in patients infected with COVID‐19.

In December 2019, a cohort of patients suffered from acute respiratory disease with unknown etiology in Wuhan, China. 1 The Chinese Center for Disease Control and Prevention detected a new coronavirus, that was previously known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, formerly dubbed as 2019-nCoV) by the International Committee on Taxonomy of Viruses. 2 The virus is highly infectious and causes fatigue, cough, fever, and severe or mild respiratory impediments. SARS-CoV-2 is termed as coronavirus disease 2019 (COVID- 19) , of which most patients exhibited mild symptoms. 3 But a fraction of the critical patients developed acute respiratory failure, septic shock, and other severe complications including acute respiratory distress syndrome (ARDS), and multiple organ dysfunction syndromes that may lead to fatal outcomes. 4 has been recognized as a Class B respiratory contagious ailment by the China Health Committee.

The WHO, on March 12, 2020, declared the COVID-19 as a global pandemic. 5 Several measures were implemented to restrain the outbreak of the disease by different governments across the globe. These measures include restrictive face-to-face communications via obligatory "social distancing" and closure of public education and recreation sites such as parks, schools, colleges, and universities. The majority of the world's population have gone through an unprecedented experience by following stern observance to the new measures. Elderly persons with co-morbid diseases such as acute kidney injury, diabetes mellitus, cardiovascular diseases, cancer, and hypertension are at higher risk of mortality or may have a more critical COVID-19. 4 13.8%-19.1% reported COVID-19 patients in Wuhan, China became patients critically. An astonishing fatality rate of 61.5% was recorded in the latest reports that increased significantly with age and for patients with comorbidities. 6 This has led to the scarcity of intensive care facilities in hospitals due to the exponential increase in the number of cases and also put enormous pressure on medical staff and services. It is unfortunate not to have any prognostic biomarker to identify patients that may need urgent medical care and the associated fatality rate. Besides this, although there is a rapid increase in COVID-19 cases, information concerning the clinical symptoms (features) is inadequate. Liu et al. 7 compared the clinical characteristics of elderly patients of COVID-19 with middle-aged and young patients. The common symptoms were fever, sputum, and cough.

The proportion of multiple lobe involvement and pneumonia severity index score was significantly higher in old patient's group compared to those in middle and young aged cohort.

Early detection of disease helps clinicians to provide necessary, timely treatment. Zheng et al. 8 Their study recorded a fatality rate of 25% in patients with HT related to COVID-19. Wu et al. 12 explored the outcomes and the clinical characteristics in COVID-19 infected patients who died or 2 | had ARDS. They extracted the risk factors related to ARDS development and death as coagulation dysfunction, neutrophilia, and older age by using bivariate Cox regression and concluded that due to less immune response, aged patients had a higher risk of ARDS development and death. Rothe et al. 13 Their machine learning method picked high-sensitivity C-reactive protein, lymphocyte, and lactic dehydrogenase as potential biomarkers that achieved 90% accuracy in mortality prediction. However, some of the features that have important effects on COVID-19 mortality rate were not investigated in these previous studies.

Therefore, in this study, we analysed additional risk factors of COVID-19 in Iran.

This study was performed prospectively from March 3, 2020 to April 8, 2020 at the imaging department of OMID hospital, Tehran, Iran. We included 319 patients with flu-like symptoms during the COVID-19 pandemic. All clinical data, including general information, epidemiological and medical history, symptoms, signs, epidemiological and clinical characteristics of patients were included. Finally, we selected 32 features (symptoms) based on consultation with four infection disease specialists. This study was approved by the local ethical committee of the university. Our patients were informed about the study aims, and written consent was obtained before enrollment and data collection.

For patients with symptoms, lung computed tomography (CT) was performed as a noninvasive test for lung situation assessment.

Unlike reverse-transcription polymerase chain reaction, which requires specific laboratory environments, CT-scan was used to provide a faster diagnosis of lung diseases. All the suspected patients underwent a thin-slice high-resolution multi-slice spiral CT scan in a supine position, and high-resolution computed tomography (HRCT) images of all patients were reviewed by a radiologist with more than 14 years of experience in chest imaging. In this manner, COVID-19 was diagnosed in suspicious cases. We followed-up with patients for two months after participation to determine their health status.

Data are presented as means ( ± standard deviations). We analyzed the features using Matlab 2016a software. Fisher's exact test 17 and Wilcoxon Rank-Sum Test 18 are used for categorical and continuous data respectively, to specify differences between the two groups.

Statistical significance was set at p ≤ .05.

A total of 319 patients (mean age 45.48 ± 18.50 years, 177 women) were recruited. Of the patients with COVID-19, one had leukemia, one advanced thyroid, and one bone marrow cancer and unfortunately, the patients with leukemia and bone marrow cancer died. Meanwhile, two cases had a stroke, and one of them was cured.

One patient with a history of tuberculosis died. Two cases had kidney disease and both of them died.

Our data showed a significant difference between healthy and COVID-19 cases with regard to the symptoms like fever (p = 1.99E−12), dyspnea (p = 2.99E−11), weakness (p = 3.16E−11), shivering (p = 1.01E−09), fatigue (p = 6.60E−09), and dry cough (p = 9.53E−09). Indeed, symptoms such as anorexia (p = 1.68E−08), the past 3 months showed no significant difference between the two classes (p = .546). We observed no significant difference between healthy and COVID-19 cases with regard to asthma (p = .715), liver disease (p = .746), cancer (p = .754), heart disease (p = 1), kidney disease (p = 1), and organ transplant (p = 1). The summary of this data is shown in Table 1 . Features with a significant relationship with COVID-19 are illustrated in Figure 1 . Meanwhile, the age distribution and a number of different blood type groups of COVID-19 patients are shown in Figure 2 . Figure 2A shows that the groups with the highest infection risk are people in the age group between 25 and 55.

They form an active labor force of society and have a higher rate of interaction with others. It is clear from Figure 2B that the negative blood groups are infected extremely less than positive groups. In positive blood groups, O+ BG, A+ BG, B+ BG, and AB+ BG are more infected, respectively.

We observed a significant association between older age with regard to mortality. The summary of this data is shown in Table 2 .

Features with a significant relationship with regard to mortality in COVID-19 are shown in Figure 3 . 

The main findings of our study are the significant association between symptoms such as fever, dyspnea, weakness, shivering, fatigue, dry cough, anorexia, anosmia, ageusia, dizziness, and sweating with COVID-19. We also observed an association between higher mean In our study, fever is the most significantly associated symptom with COVID-19, which is in line with findings by Zhang et al. 21 and

Chen et al. 22 In contrast, Liang et al., 23 DeBiasi et al., 24 Tian et al., 25 Zho et al., 26 and Qin et al. 27 found a nonsignificant association between fever and COVID-19. Indeed, dyspnea is a relevant symptom with COVID-19 that is in agreement with Tian et al., 25 DeBiasi et al., 24 and Qin et al. 27 but is in contrast with the findings of Liang et al. 23 and

Yan et al. 28 Dizziness is associated with COVID-19 in our study, which is similar to the findings of Zhou et al. 29 and Zhang et al. 30 But Shi et al., 17 Chen et al., 22 and Liang et al. 23 found no association with this.

We did not find a study regarding sweating, and to the best of our knowledge, this is the first work to report this. Nikpouraghdam et al. 31 suggested an association between weakness and COVID-19 that is the same as our data but is in contrast with the findings of Shi et al. 17 Shivering is observed in the cohort of COVID-19, which is reported by Zhu et al. 32 too. Fatigue is significantly related with COVID-19 in our cohort which confirms the findings of Qin et al. 27 but is in contrast to the findings of Liang et al., 23 Tian et al., 25 Lei et al., 33 and Yan et al. 34 A dry cough is reported by Du et al. 35 to be related with COVID-19, which is similar with our findings, while such an association is not found by Qin et al., 27 Lei et al., 33 and Shi et al. 17 Anorexia is found to be a significant symptom for COVID-19 in our study. The association between anorexia and COVID-19 in our study is similar to Zhang et al. 21 and Chen et al. 22 but is not in line with the findings of Shi et al., 17 Lei et al., 33 and Qin et al. 27 Anosmia is associated with COVID-19 in our cohort, which confirms the findings of Yan et al., 28 Bagheri et al., 36 and Lee et al. 37 Yan et al. 28 and Lee et al. 37 also introduced ageusia as an associated symptom with COVID-19 that is in line with our findings.

Regarding the association between age and COVID-19, we observed old age, as an indicator. which is in line with Fan et al., 38 but is in contrast with the findings of Fu et al., 39 Fang et al., 40 and Omrani-Nava et al., 41 who did not find a significant association between age and COVID-19. This discrepancy could be explained by different demographic features (symptoms). We observed elevated CRP as a related feature to COVID-19 in our investigation that is in agreement with Fu et al. 39 and is in contrast with the findings of Omrani-Nava et al. 41 BCG vaccination showed no significant relationship between COVID-19 versus healthy subjects in our cohort that is in agreement with the findings of Li et al. 42 and Hamiel et al. 10 and in contrast to Dayal et al. 43 Currently 26 report, which is also observed in our findings. Zhou et al. 26 reported other predictors of mortality such as fever, fatigue, myalgia, nausea, vomiting, diarrhea, cough, and sputum that are not mortality predictors in our cohort. Fever and dyspnea are also considered as predictors of mortality by Iftime et al. 44 and Chen et al., 45 respectively, while we did not find an association between these symptoms with COVID-19 related mortality.

Interestingly, we observed more features associated with mortality in our cohort, but age seems to be the most important risk factor for COVID-19, which is in line with other published studies. 26 and also there is a possibility of increased respiratory disease. As mentioned above, comorbidities such as cancer and underlying heart diseases are associated with COVID-19 mortality. Iftimie et al. 44 observed such an association with T2D and cancer, but they negated the relationship between the history of heart disease and COVID-19 related mortality.

Regarding comorbidities, Ruan et al. 48 and Chen et al. 45 demonstrated a link between a history of heart disease and COVID-19 related mortality.

Furthermore, a history of cerebrovascular disease is also a determinant in the Chen et al. 45 cohort. Male gender was associated with COVID-19 related mortality in a study by Li et al. 49 study, but we did not observe such an association in our cohort. Positive CRP is a predictor in Ruan et al. 48 study, while it did not have any association with mortality in our investigation.

The association between a certain type of blood group and COVID-19 related mortality is the novel finding of our investigation.

We observed a protective role for O− BG against COVID-19 in our cohort that is similar to the findings of Zietz et al. 50 Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; CI, confidence interval; eGFR, estimated glomerular filtration rate; FEU, fibrinogen equivalent units; hs-CRP, high-sensitivity C-reactive protein; hs-TnI, high-sensitivity cardiac troponin I; LYM, lymphocyte; NT-proBNP, aminoterminal pro-brain natriuretic peptide; OR, odds ratio; PCT, procalcitonin; SpO 2 , oxygen saturation; WBC, white blood cell.

Investigation of a COVID-19 outbreak in Germany resulting from a single travelassociated primary case: a case series

A novel coronavirus from patients with pneumonia in China

COVID-19) situation report-114

A machine learning-based model for survival prediction in patients with severe COVID-19 infection

Peer influence in adolescence: public-health implications for COVID-19

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Clinical features of COVID-19 in elderly patients: a comparison with young and middle-aged patients

Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu

Clinical features of COVID-19-related liver functional abnormality

SARS-CoV-2 rates in BCG-vaccinated and unvaccinated young adults

Characteristics and outcomes of recipients of heart transplant with coronavirus disease 2019

Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China

Transmission of 2019-nCoV infection from an asymptomatic contact in Germany

Large-vessel stroke as a presenting feature of Covid-19 in the young

Spread of SARS-CoV-2 in the Icelandic population

Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes

Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study

A multiple comparison rank sum test: treatments versus control

Distribution of blood groups in the Iranian general population

Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan

Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19

Prevalence and clinical features of 2019 novel coronavirus disease (COVID-19) in the Fever Clinic of a teaching hospital in Beijing: a single-center

Severe COVID-19 in children and young adults in the Washington, DC metropolitan region

Characteristics of COVID-19 infection in Beijing

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Dysregulation of Immune Response in Patients With Coronavirus

Selfreported olfactory loss associates with outpatient clinical course in COVID-19

Effect of gastrointestinal symptoms in patients with COVID-19

Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China

Comparison of clinical, laboratory and radiological findings in Iranian smokers and non-smokers patients with COVID-19: a case control study

Clinicopathological characteristics of 8697 patients with COVID-19 in China: a meta-analysis

Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection

Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms

Clinical characteristics of COVID-19 in children compared with adults in Shandong Province

Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak

Prevalence and duration of acute loss of smell or taste in COVID-19 patients

Hematologic parameters in patients with COVID-19 infection

The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: a retrospective study in Suzhou China

Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19

Evaluation of hepatic enzymes changes and association with prognosis in COVID-19 patients

The correlation between BCG immunization coverage and the severity of COVID-19

Connecting BCG vaccination and COVID-19: additional data

Risk factors associated with mortality in hospitalized patients with SARS-CoV-2 infection. A prospective, longitudinal, unicenter study in Reus

Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in China

Risk factors for mortality in 244 older adults with COVID-19 in Wuhan, China: a retrospective study

Frailty and mortality in hospitalized older adults with COVID-19: retrospective observational study

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan

Testing the association between blood type and COVID-19 infection, intubation, and death. medRxiv. 2020;1-17

Diabetes is a risk factor for the progression and prognosis of COVID-19

Inhibition of the interaction between the SARS-CoV Spike protein and its cellular receptor by antihisto-blood group antibodies

Relationship between the ABO blood group and the COVID-19 susceptibility

Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis

Onset of occupational hand eczema among healthcare workers during the SARS-CoV-2 pandemic: comparing a single surgical site with a COVID-19 intensive care unit

Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis

COVID-19 with different severities: a multicenter study of clinical features

Falling stroke rates during COVID-19 pandemic at a comprehensive stroke center: cover title: falling stroke rates during COVID-19

Favipiravir versus arbidol for COVID-19: a randomized clinical trial

Characteristics and clinical outcomes of adult patients hospitalized with COVID-19-Georgia

COVID-19 in solid organ transplant recipients: initial report from the US epicenter

Determining risk factors for mortality in liver transplant patients with COVID-19

Early short course corticosteroids in hospitalized patients with COVID-19

Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19

How to cite this article: Alizadehsani R

Risk factors prediction, clinical outcomes, and mortality in COVID-19 patients